BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11727264)

  • 1. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma.
    Chen CL; Sheen TS; Lou IU; Huang AC
    Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
    Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
    Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
    Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck?
    Vural E; Alexiou M; Hunt J; Korourian S; Hanna E
    Am J Otolaryngol; 2001; 22(4):257-60. PubMed ID: 11464322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
    Ou XB; Chen XY; Wu MH; Luo WR
    Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
    Gondhowiardjo S
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutathione-S-transferase expression in oral squamous cell carcinoma].
    Pannone G; Lo Muzio L; Pappalardo S; Bambini F; Rubini C; Fioroni M; Fanali S
    Minerva Stomatol; 2000 Mar; 49(3):107-17. PubMed ID: 20047209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
    Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
    Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.